Brief: Biosergen Q4 Loss Narrows To SEK 3.7 Mln

Biosergen AB

05/03/2025 07:41

March 5 (Reuters) - Biosergen AB BIOSGN.ST:

Q4 LOSS SEK 3.7 MILLION VERSUS LOSS SEK 6.5 MILLION YEAR AGO

DELAY IN COHORT 3 WILL NOT AFFECT ANY PLANNED ACTIVITIES OUTSIDE OF INDIA FOR 2025

Source text: ID:nWkr72js95

Further company coverage: BIOSGN.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))